贝尔法斯特女王大学的研究人员开发了一种阴道环，能够持续输送Ob-002 (5p12-Rantes)以预防艾滋病
13 févr. 2019 00h20 HE
|
Orion Biotechnology Canada Ltd
渥太华, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd.是一家新型医疗产品的开发商。该公司今天宣布，贝尔法斯特女王大学药学院的研究人员在《缓控释杂志》上发表了一篇文章，描述了一种新的阴道内环（IVR）设计，它可以持续输送逆转录病毒蛋白OB-002...
Researchers at Queen’s University Belfast have Developed a Vaginal Ring Capable of Providing Sustained Delivery of OB-002 (5P12-RANTES) for HIV Prevention
12 févr. 2019 09h00 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that researchers at the School of Pharmacy, Queen’s University...
Orion Biotechnology Canada report that IND- enabling studies evaluating the safety of their OB-002H microbicide gel have shown an excellent mucosal safety profile
29 janv. 2019 08h58 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data evaluating the safety of OB-002H (5P12-RANTES)...
Orion Biotechnology在临床前研究中报告了结直肠癌的阳性结果
15 janv. 2019 16h25 HE
|
Orion Biotechnology Canada Ltd
渥太华, Jan. 16, 2019 (GLOBE NEWSWIRE) -- 新型医疗治疗开发商Orion Biotechnology Canada Ltd.今天宣布了与Charles River Laboratories合作生产的临床前数据，该数据被用于评估OB-002O（5P12-RANTES）治疗结直肠癌的疗效。用CT-26结肠直肠癌细胞系皮下接种BALB /...
Orion Biotechnology Reports Positive Results for Colorectal Cancer in Preclinical Study
15 janv. 2019 09h00 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data produced in collaboration with Charles River...
Orion Biotechnology完成与MHRA的科研意见会谈
01 nov. 2018 11h43 HE
|
Orion Biotechnology Canada Ltd
大渥太华, Nov. 01, 2018 (GLOBE NEWSWIRE) -- 新型医疗方案开发商Orion Biotechnology Canada Ltd.今日宣布，已与英国药品与保健品监管局（MHRA）完成有关公司创新的杀微生物剂候选药物OB-002H的科研意见会谈。在此之前，该公司也与美国食品药物管理局进行了新药临床试验申请前的沟通。 ...
Orion Biotechnology Completes Scientific Advice Meeting with MHRA
31 oct. 2018 11h19 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, announced today the completion of a scientific advice meeting with the Medicines...
Orion Biotechnology收购强效CCR5趋化因子拮抗剂相关专利组合
09 sept. 2018 19h00 HE
|
Orion Biotechnology Canada Ltd
加拿大渥太华, Sept. 10, 2018 (GLOBE NEWSWIRE) -- 新型医药治疗研发商Orion Biotechnology Canada Ltd.今日宣布，旗下子公司Orion Biotechnology Switzerland Sàrl已成功完成向Mintaka Medical Research...
Orion Biotechnology acquires patent portfolio for potent CCR5 chemokine antagonist
06 sept. 2018 13h08 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its subsidiary, Orion Biotechnology Switzerland Sàrl, has...
Orion Biotechnology获波兰国家研究开发中心拨款200万美元资助HIV杀菌剂的进一步开发
18 juil. 2018 10h56 HE
|
Orion Biotechnology Canada Ltd
渥太华, July 18, 2018 (GLOBE NEWSWIRE) -- 讯：新型医疗开发商Orion Biotechnology Canada Ltd.今日宣布，旗下的欧洲子公司Orion Biotechnology Polska Sp. z...